Anti-PRPF31 antibody [EPR14587]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal PRPF31 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Rat, Human samples. Cited in 7 publications.
View Alternative Names
PRP31, PRPF31, U4/U6 small nuclear ribonucleoprotein Prp31, Pre-mRNA-processing factor 31, Serologically defined breast cancer antigen NY-BR-99, U4/U6 snRNP 61 kDa protein, Protein 61K, hPrp31
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PRPF31 antibody [EPR14587] (AB188577)
Immunofluorescence analysis of paraformaldehyde-fixed HeLa cells labeling PRPF31 with ab188577 at a 1/250 dilution. As secondary antibody goat anti-rabbit IgG (Alexa Fluor®488) was used at a 1/200. In blue DAPI staining.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-PRPF31 antibody [EPR14587] (AB188577)
Intracellular Flow Cytometry analysis of paraformaldehyde-fixed HeLa cells labeling PRPF31 with ab188577 at a 1/240 dilution and secondary antibody goat anti-rabbit IgG (FITC, red) at a 1/150 dilution, or negative control rabbit IgG (green).
- WB
Supplier Data
Western blot - Anti-PRPF31 antibody [EPR14587] (AB188577)
All lanes:
Western blot - Anti-PRPF31 antibody [EPR14587] (ab188577) at 1/10000 dilution
Lane 1:
HeLa cell lysate at 20 µg
Lane 2:
Jurkat cell lysate at 20 µg
Secondary
All lanes:
goat anti-rabbit IgG, (H+L), peroxidase conjugated at 1/1000 dilution
Predicted band size: 55 kDa
Observed band size: 55 kDa
true
- WB
Supplier Data
Western blot - Anti-PRPF31 antibody [EPR14587] (AB188577)
All lanes:
Western blot - Anti-PRPF31 antibody [EPR14587] (ab188577) at 1/1000 dilution
All lanes:
Rat spleen tissue lysate at 10 µg
Secondary
All lanes:
goat anti-rabbit IgG, (H+L), peroxidase conjugated at 1/1000 dilution
Predicted band size: 55 kDa
Observed band size: 55 kDa
true
- WB
CiteAb
Western blot - Anti-PRPF31 antibody [EPR14587] (AB188577)
PRPF31 western blot using anti-PRPF31 antibody [EPR14587] ab188577. Publication image and figure legend from Zuo, S., Li, X., et al., 2020, Sci Rep, PubMed 32483193.
ab188577 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab188577 please see the product overview.
The expression of PRP3 is increased in cSCC cells and tissues. (A) PRP3 mRNA expression in cSCC cells compared with benign epidermal keratinocyte cells. (B) PRP3 protein expression in cSCC cells compared with benign epidermal keratinocyte cells. (C) Relative protein expression of PRP3 in cSCC cells versus benign epidermal keratinocyte cells. (D) PRP3 protein expression in cSCC tissues was examined via western-blot. (E) PRP3 protein expression in normal human skin, AK, cSCCs in situ and sporadic cSCCs tissues were explored via IHC. (F) High PRP3 expression is associated with poor prognosis in cSCCs patients. *p < 0.05, **p < 0.01. PRP3, pre-mRNA processing factor 3.
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PRPF31 is involved in RNA splicing a process fundamental for gene expression. It forms part of the U4/U6-U5 snRNP complex which is responsible for catalyzing the splicing of pre-mRNA. PRPF31 facilitates the rearrangement of RNA and protein components within the spliceosome ensuring accurate splicing and removal of introns.
Pathways
The protein plays a role in the spliceosome pathway and genetic information processing. PRPF31 interacts with other splicing factors like PRPF6 and SNRNP200 within these pathways. Its activity is important for maintaining the fidelity and efficiency of spliceosome assembly and function linking gene regulation and expression to various cellular responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
EMBO molecular medicine 15:e17973 PubMed37800682
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:3646 PubMed34131137
2021
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:8863 PubMed32483193
2020
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 13:4717-4730 PubMed32547101
2020
Applications
Unspecified application
Species
Unspecified reactive species
Archives of biochemistry and biophysics 677:108159 PubMed31669268
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 119:6775-6783 PubMed29744916
2018
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 46:3774-3790 PubMed29415178
2018
Applications
Unspecified application
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com